Cargando…
Functional Blockade of E-Selectin in Tumor-Associated Vessels Enhances Anti-Tumor Effect of Doxorubicin in Breast Cancer
Chemotherapy is a mainstay of treatment for solid tumors. However, little is known about how therapy-induced immune cell infiltration may affect therapy response. We found substantial CD45(+) immune cell density adjacent to E-selectin expressing inflamed vessels in doxorubicin (DOX)-treated residual...
Autores principales: | Morita, Yoshihiro, Leslie, Macall, Kameyama, Hiroyasu, Lokesh, Ganesh L. R., Ichimura, Norihisa, Davis, Rachel, Hills, Natalie, Hasan, Nafis, Zhang, Roy, Kondo, Yuji, Gorenstein, David G., Volk, David E., Chervoneva, Inna, Rui, Hallgeir, Tanaka, Takemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140021/ https://www.ncbi.nlm.nih.gov/pubmed/32204492 http://dx.doi.org/10.3390/cancers12030725 |
Ejemplares similares
-
Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomas
por: Morita, Yoshihiro, et al.
Publicado: (2017) -
Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
por: Hills, Natalie, et al.
Publicado: (2021) -
The effect of soluble E-selectin on tumor progression and metastasis
por: Kang, Shin-Ae, et al.
Publicado: (2016) -
Erratum to: The effect of soluble E-selectin on tumor progression and metastasis
por: Kang, Shin-Ae, et al.
Publicado: (2016) -
Aptamer Therapeutics in Cancer: Current and Future
por: Morita, Yoshihiro, et al.
Publicado: (2018)